Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05291598 · ClinicalTrials.gov registry record · Phase 3
Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)
A Phase 3 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 3
- Development phase
- 223
- Enrollment target
NCT05291598 is a Phase 3 study that has completed, run by University of Miami. The registered enrollment target is 223 participants.
The verdict
NCT05291598, a Phase 3 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 223 participants
- Enrollment target
Study Summary
The purpose of this project is to determine if a change in patient reported pain, nausea and vomiting after total knee and hip arthroplasty could be observed with the substitution of Intravenous meloxicam for ketorolac in the current established peri-operative pain protocol and if these changes lead to a decrease in opioid consumption (in morphine equivalents).
Interventions
- DRUG Ketorolac
- DRUG IV meloxicam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2022-05-01 |
| Est. Completion | 2023-05-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05291598
The ClinicalTrials.gov registry entry for NCT05291598 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT05291598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05291598 about?
NCT05291598 is a clinical study titled "Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)". The purpose of this project is to determine if a change in patient reported pain, nausea and vomiting after total knee and hip arthroplasty could be observed with the substitution of Intravenous meloxicam for ketorolac in the current established peri-operative pain protocol and if these changes lead...
What is the current status of trial NCT05291598?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 223 participants. The study started on 2022-05-01. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT05291598?
The interventions under investigation include: Ketorolac (DRUG), IV meloxicam (DRUG).
Who is sponsoring clinical trial NCT05291598?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.